---
title: "West Pharmaceutical (WST.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/WST.US/norm.md"
symbol: "WST.US"
name: "West Pharmaceutical"
parent: "https://longbridge.com/en/quote/WST.US.md"
datetime: "2026-05-20T06:38:28.421Z"
locales:
  - [en](https://longbridge.com/en/quote/WST.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/WST.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/WST.US/norm.md)
---

# West Pharmaceutical (WST.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 1.92 | 1.82 | 1.92 | 1.82 | 1.23 |
| ROE | 18.01% | 16.97% | 18.73% | 18.79% | 13.39% |
| Revenue | 844.90M | 805.00M | 804.60M | 766.50M | 698.00M |
| Net income | 138.80M | 132.10M | 140.00M | 131.80M | 89.80M |
| Operating income | 183.30M | 174.20M | 175.80M | 160.00M | 128.70M |
| Gross margin | 35.08% | 37.75% | 36.58% | 35.73% | 33.22% |
| Net margin | 16.43% | 16.41% | 17.40% | 17.20% | 12.87% |
| Profit quality | 203.89% | 69.37% | 89.15% | 90.34% | 99.46% |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 4.11B | 4.27B | 4.11B | 3.95B | 3.62B |
| Leverage | 1.37 | 1.34 | 1.35 | 1.35 | 1.35 |
| BVPS | 42.18 | 44.11 | 42.44 | 40.74 | 37.37 |
| Turnover | 0.8336 | 0.7769 | 0.7757 | 0.7955 | 0.8021 |
| Cash & STI | 521.40M | 791.30M | 628.50M | 509.70M | 404.20M |
| Inv & Rec | 452.60M | 443.90M | 438.00M | 421.10M | 388.70M |
| LT assets | 1.85B | 1.88B | 1.87B | 1.86B | 1.77B |
| Net debt | -200.40M | -465.10M | -325.50M | -201.50M | -96.80M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 89.90M | 251.10M | 197.20M | 177.10M | 129.40M |
| Investing CF | -42.70M | -76.10M | -63.30M | -75.20M | -71.30M |
| Financing CF | -308.70M | -11.70M | -11.50M | -14.90M | -147.00M |
| Free CF | 25.56M | 112.58M | 104.47M | 34.30M | 22.84M |
| OCF coverage | 152.89% | 272.34% | 250.57% | 195.47% | 149.25% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -42.70M | -76.10M | -63.30M | -75.20M | -71.30M |

## Distribution Plan

**Dividend Yield**: 0.29

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.22USD | 2026-04-29 | 2026-04-29 | 2026-05-06 |
| Cash Dividend: 
0.22USD | 2026-01-28 | 2026-01-28 | 2026-02-04 |
| Cash Dividend: 
0.22USD | 2025-11-12 | 2025-11-12 | 2025-11-19 |